Jocasta Neuroscience
Northbrook
About Jocasta Neuroscience
Jocasta Neuroscience, Inc. is a preclinical-stage biotechnology company that specializes in developing therapies for cognitive impairment associated with neurodegenerative diseases, focusing on the biology of healthy aging and longevity. Jocasta is pioneering scientifically backed solutions for healthy cognitive aging, leveraging breakthrough research in longevity biology. With deep expertise and exclusive IP, Jocasta stands at the forefront of developing novel therapeutics for dementia and related conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $66.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: jocastaneuro.com
- Phone: +1 847-960-3840
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Neuroscience
Canonical: https://fsome.com/organization/jocasta-neuroscience-3162 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.